A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
Condition: Langerhans Cell HistiocytosisIntervention: Drug: GSK2110183Sponsors: Octagon Research Solutions, Inc.; Octagon Research Solutions, Inc.Active, not recruiting - verified March 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials